5Baoli C. Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients [J]. Crit Care Meal,2007,35 : 2538 -2546.
6Van den Berghe C, Wou ters P, W eekers F, et al. Intensive insulin therapy in critically ill patients [ J ]. N Engl J Med, 2001,345 ( 8 ) : 1359 - 1367.
7DelIinger RP, LevyMM, Carlet JM, et al. Surviving sep sis eampaigu: International guide-lines for management of severe sep sis and sep tic shock :2008 [ J ]. Crit Care Med ,2008,36 ( 1 ) :296 - 327.
8Loisal P, Parviainen I, Tenhunen J, et al. Effect of mode of hydrocortisone administration on glycemic control in patientswith sep tic shock: A prospective randomized trial [ J ]. Crit Care, 2007, 11 (1):113.
9Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis [ J ]. N Engl J Med, 2001,344:690 - 709.
10Marti-Carvajal A , Salanti G, Cardona AF. Human recombinant activated protein C for severe sepsis[J]. Cochrane Database Syst Rev,2007, 3 : CD004388.
